Company Filing History:
1 out of 1 
1 out of 3 
1 out of 14 Years Active: 2012-2014
Title: The Innovative Contributions of Elisa Ciraolo
Introduction
Elisa Ciraolo is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific kinase activities. With a total of 2 patents, her work has implications for the treatment of various pathological conditions.
Latest Patents
Ciraolo's latest patents include "Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases." This patent focuses on compounds that are capable of inhibiting kinase activity, specifically targeting Phosphatidylinositol 3-Kinases. The disclosure also discusses the use of these compounds for treating conditions associated with alterations in Phosphatidylinositol 3-Kinases activity. Another notable patent is "Regulation of expression of PI3Kβ protein in tumors." This patent describes the use of the PI3Kβ protein and its encoding gene for screening substances useful in cancer treatment, particularly breast cancer. It also outlines a method for diagnosing malignant cell growth by measuring the expression of PI3Kβ.
Career Highlights
Elisa Ciraolo has worked at prestigious institutions, including the Università Degli Studi Di Torino and the Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro." Her research has focused on the molecular mechanisms underlying cancer and the development of innovative therapeutic strategies.
Collaborations
Ciraolo has collaborated with notable colleagues such as Emilio Hirsch and Giovanni Sorba. These partnerships have enhanced her research and contributed to the advancement of knowledge in her field.
Conclusion
Elisa Ciraolo's innovative work in biochemistry and her contributions to cancer research highlight her role as a leading inventor. Her patents reflect a commitment to developing effective treatments for serious health conditions.